Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Constipation
ADR ID BADD_A01059
ADR Hierarchy
07      Gastrointestinal disorders
07.02      Gastrointestinal motility and defaecation conditions
07.02.02      Gastrointestinal atonic and hypomotility disorders NEC
07.02.02.001      Constipation
Description A disorder characterized by irregular and infrequent or difficult evacuation of the bowels. [CTCAE] Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. | Difficult defecation. | Symptom characterized by the passage of stool once a week or less. [MeSH]
MedDRA Code 10010774
MeSH ID D003248
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Constipation | Constipation (excl faecal impaction) | Iatrogenic constipation | Obstipation | Constipation aggravated | Constipation (excl fecal impaction) | Stools absent | Constipation chronic | Opioid induced constipation | Slow transit constipation | Chronic idiopathic constipation | Dyschezia | Colonic Inertia
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02486Niraparib0.019714%
BADD_D02487Baricitinib0.002316%
BADD_D02489Neratinib0.023711%
BADD_D02490Apalutamide--
BADD_D02491Valbenazine--
BADD_D02492Deflazacort0.003146%
BADD_D02495Duvelisib0.000533%
BADD_D02496Elagolix0.007841%
BADD_D02497Avatrombopag0.001089%
BADD_D02498Abemaciclib0.004263%
BADD_D02500Alpelisib--
BADD_D02503Telotristat ethyl-
BADD_D02507Deutetrabenazine--
BADD_D02509Brigatinib0.001332%
BADD_D02510Rucaparib0.053282%
BADD_D02511Siponimod--
BADD_D02514Etelcalcetide--
BADD_D02516Plecanatide0.003050%
BADD_D02517Enasidenib0.002131%
BADD_D02518Semaglutide0.016275%
BADD_D02521Sodium zirconium cyclosilicate0.032071%
BADD_D02522Lithium citrate-
BADD_D02524Ivosidenib0.001332%
BADD_D02526Larotrectinib0.000799%
The 40th Page    First    Pre   40    Total 40 Pages